Altos Labs IPO

altoslabs.com

Altos Labs was founded in 2022 by Richard D. Klausner and Hans Bishop. The company has not officially endorsed a plan to participate in an IPO. These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.

Altos is a biotech company dedicated to exploring cellular rejuvenation technologies with the goal of developing life extension therapies that could slow or stop the aging process. The company's board is composed of prominent scientific figures as well as four Nobel laureates. Altos launched with $3 billion in private funding, making it already one of the most well-funded biotech companies in the world. Investors include Jeff Bezos, Yuri Milner, and ARCH Venture Partners. The company has not released any valuation figures.

Founded2021
Total Funding to Date$1.16B
Register for Details

For more details on financing and valuation for Altos Labs, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Altos Labs Ticker Symbol

Altos Labs does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Altos Labs Stock Price

The stock price for Altos Labs will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Major Investors for Altos Labs

Arch Venture Partners
Foresite Capital
Mubadala Investment Company

Altos Labs Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
3/25/2022 Series B $819.55MM raised $XXX.XX $XXX.XX
9/4/2021 Series A $336.39MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Altos Labs in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
 
 
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM
Sector